LabCompass

Paul R. Territo

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1998Rising activity
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and TreatmentsCancer Research and Treatments

Publications

266

Citations

3,988

Est. group size

~4

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Paul R. Territo studies Alzheimer's disease and related dementias, with a focus on preclinical mouse models and brain imaging. Much of the work examines how genetic risk variants and environmental toxicant exposures (such as lead, cadmium, and arsenic) contribute to disease progression, and how therapeutic candidates can be tested and translated toward clinical use. The research combines neuroimaging, molecular characterization, and standardized experimental protocols.

Alzheimer's disease mouse modelsBrain and preclinical imagingEnvironmental neurotoxicants and disease riskGene-environment interactions in dementiaPreclinical therapeutic testing and translation

Publication activity has remained active and generally high over the past decade, averaging around 24 papers per year in recent years, with a notable peak in 2023.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through August 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH U54AG054345through Aug 2027 · $9.8M awarded

    IU/JAX/PITT MODEL-AD Center

  • ActiveNIH R21AG083791through May 2027 · $249k awarded

    Targeting P2RX7 Signaling as a Biomarker for ADRD

4 earlier awards
  • NIH R56AG085396Sep 2024 – Aug 2026 · $792k awarded

    Targeting P2RX7 Signaling as a Treatment for ADRD

  • NIH R21AG078575Aug 2022 – Jul 2025 · $469k awarded

    Modulation of TNFα as a Treatment for Alzheimer's Disease and Related Dementia

  • NIH R21AG067923Feb 2020 – Nov 2023 · $198k awarded

    The Pathogenic Role of Pb in Cerebral Amyloid Angiopathy and AD

  • NIH R01CA206025May 2016 – Apr 2021 · $20k awarded

    (PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 5,073 established Medicine PIs within our index
Citations: 3,988cohort median 2,525
h-index: 34cohort median 24
Publications / year (recent): 24.4cohort median 4.8

Typically publishes in teams of ~7 · 15% small-team papers (≤3 authors) · across 31 venues

Publication cadence
Publications per year over the last 10 years — averaging 24.4/year recently
2017: 16 publications172018: 15 publications182019: 20 publications192020: 22 publications202021: 10 publications212022: 14 publications222023: 54 publications54232024: 19 publications242025: 24 publications252026: 11 publications26
Recent publications
Publishes in
  • Alzheimer s & Dementia×61
  • bioRxiv (Cold Spring Harbor Laboratory)×11
  • PMC×10
  • Alzheimer s & Dementia Translational Research & Clinical Interventions×6
  • Frontiers in Aging Neuroscience×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile